Business Segment, Product and Geographic Information

The Company’s business operates in one segment based upon the Company’s organizational structure, the way in which the operations are managed and evaluated by the chief operating decision maker and the lack of availability of discrete financial information.

The company operates under three products lines for revenues; Spine Surgery Products, Biologics and Monitoring Service. The Company’s Spine Surgery Product line offerings, which include thoracolumbar product offerings, cervical product offerings and disposables, are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The Company’s Biologic product line offerings includes allograft (donated human tissue), FormaGraft^®, a collagen synthetic product, Osteocel^® Plus and Osteocel^®Pro, an allograft cellular matrix containing viable mesenchymal stem cells, or MSCs, and AttraX^®, a synthetic bone graft material, all used to aid the spinal fusion or bone healing process. The Company’s Monitoring Service offering includes IOM services. Revenue by product line offerings was as follows (in thousands):



	Three Months Ended June 30,				Six Months Ended June 30,
	2014		2013		2014		2013
Spine Surgery Products	$	147,333	$	128,682	$	284,640	$	251,348
Biologics	32,837		27,855		62,327		55,012
Monitoring Service	10,507		9,161		21,205		18,842
Total Revenue	$	190,677	$	165,698	$	368,172	$	325,202

Revenue and property and equipment, net, by geographic area were as follows (in thousands):



	Revenue								Property and Equipment, Net
	Three Months Ended June 30,				Six Months Ended June 30,				June 30,		December 31,
	2014		2013		2014		2013		2014		2013
United States	$	167,077	$	151,425	$	325,470	$	297,646	$	110,625	$	109,458
International (excludes Puerto Rico)	23,600		14,273		42,702		27,556		24,238		18,606
Total	$	190,677	$	165,698	$	368,172	$	325,202	$	134,863	$	128,064